CytoMed Therapeutics Limited(NASDAQ:GDTC) 
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D liga...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.42
H 2.47
L 2.26
C 2.38
V 8,281
10EMA 2.38
20EMA 2.38
60EMA 2.38
120EMA 2.38
250EMA 2.38